Results 21 to 30 of about 151,694 (306)

Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma [PDF]

open access: yes, 2011
PURPOSE: This analysis from an observational study of clinical practice describes the impact of febrile neutropenia (FN) on chemotherapy delivery and hospitalizations.
Rossi, F G   +46 more
core   +1 more source

Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer [PDF]

open access: yes, 2012
Background: Febrile neutropenia is a frequently occurring and occasionally life-threatening complication of treatment for childhood cancer. Many biomarkers have been proposed as predictors of adverse events.
Phillips Robert S   +19 more
core   +2 more sources

C16orf57, a gene mutated in poikiloderma with neutropenia, encodes a putative phosphodiesterase responsible for the U6 snRNA 3′ end modification. [PDF]

open access: yes, 2012
C16orf57 encodes a human protein of unknown function, and mutations in the gene occur in poikiloderma with neutropenia (PN), which is a rare, autosomal recessive disease.
Krwawicz, Joanna   +6 more
core   +1 more source

European surveillance of infections in cancer patients - ESIC [PDF]

open access: yes, 1999
Major advances in cancer therapy result from development of multidrug chemotherapy regimens. Besides death from tumor progression, infections are currently one of the major causes of mortality and morbidity.
Krcmery, V.   +7 more
core   +1 more source

Clinical manifestations and outcomes of pediatric chronic neutropenia

open access: yesJournal of the Formosan Medical Association, 2012
Neutropenia is a decrease in the number of circulating neutrophils. When neutropenia persists for more than 3 months, it becomes chronic. A heterogeneous group of diseases in children can cause chronic neutropenia.
Chuan Wan   +7 more
doaj   +1 more source

Drug-induced neutropenia in female patient with reactive arthritis

open access: yes, 2022
Drug-induced neutropenia is relatively rare, but it is a severe and unfavorable prognostic complication of pharmacotherapy. One of the main causes of drug-induced neutropenia is the use of cytostatic drugs - an integral part of the treatment of many ...
Alexander A. Kopelev   +6 more
core   +1 more source

Biological treatment in Felty's Syndrome with profound neutropenia

open access: yes, 2023
A triad of symptoms characterises Felty's syndrome: seropositive rheumatoid arthritis (RA), splenomegaly and neutropenia. The treatment of Felty's syndrome is based on using classic synthetic and biological disease-modifying drugs (DMARDs).
Marta Madej   +3 more
core   +1 more source

Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease

open access: yesEndocrine Connections, 2023
Objective: Neutropenia is a complication of Graves' disease (GD), but there is currently no means by which to predict its occurrence. This study aimed to investigate the risk factors for the development of neutropenia in untreated GD. Methods: This was
Qian Yang   +5 more
doaj   +1 more source

Neonatal Diamond-Blackfan anemia with persistent neutropenia caused by an <i>RPS15A</i> variant. [PDF]

open access: yesPediatr Investig
Pediatric Investigation, EarlyView.
Zheng H   +5 more
europepmc   +2 more sources

Clinical spectrum of pediatric neutropenia: mostly benign, but not to be overlooked

open access: yesThe Turkish Journal of Pediatrics
Background. Neutropenia is a common laboratory finding in children, therefore it is a common referral reason to pediatric hematology units. This study hypothesizes that most neutropenic children do not require pediatric hematology consultation, and that
Şefika Akyol   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy